370 related articles for article (PubMed ID: 34676001)
1. Glioblastoma pharmacotherapy: A multifaceted perspective of conventional and emerging treatments (Review).
Sevastre AS; Costachi A; Tataranu LG; Brandusa C; Artene SA; Stovicek O; Alexandru O; Danoiu S; Sfredel V; Dricu A
Exp Ther Med; 2021 Dec; 22(6):1408. PubMed ID: 34676001
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R
Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme.
Aldoghachi AF; Aldoghachi AF; Breyne K; Ling KH; Cheah PS
Neuroscience; 2022 May; 491():240-270. PubMed ID: 35395355
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM).
Yalamarty SSK; Filipczak N; Li X; Subhan MA; Parveen F; Ataide JA; Rajmalani BA; Torchilin VP
Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046777
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies.
Liu D; Dai X; Ye L; Wang H; Qian H; Cheng H; Wang X
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023 Jan; 15(1):e1838. PubMed ID: 35959642
[TBL] [Abstract][Full Text] [Related]
6. New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective.
Sestito S; Runfola M; Tonelli M; Chiellini G; Rapposelli S
Front Pharmacol; 2018; 9():874. PubMed ID: 30123135
[TBL] [Abstract][Full Text] [Related]
7. Emerging treatment strategies for glioblastoma multiforme.
Carlsson SK; Brothers SP; Wahlestedt C
EMBO Mol Med; 2014 Nov; 6(11):1359-70. PubMed ID: 25312641
[TBL] [Abstract][Full Text] [Related]
8. A narrative review of research progress on drug therapies for glioblastoma multiforme.
Zheng X; Tang Q; Ren L; Liu J; Li W; Fu W; Wang J; Du G
Ann Transl Med; 2021 Jun; 9(11):943. PubMed ID: 34350258
[TBL] [Abstract][Full Text] [Related]
9. Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.
Polivka J; Polivka J; Holubec L; Kubikova T; Priban V; Hes O; Pivovarcikova K; Treskova I
Anticancer Res; 2017 Jan; 37(1):21-33. PubMed ID: 28011470
[TBL] [Abstract][Full Text] [Related]
10. Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches.
Miranda A; Blanco-Prieto M; Sousa J; Pais A; Vitorino C
Int J Pharm; 2017 Oct; 531(1):372-388. PubMed ID: 28755993
[TBL] [Abstract][Full Text] [Related]
11. A guide through conventional and modern cancer treatment modalities: A specific focus on glioblastoma cancer therapy (Review).
Naser R; Dilabazian H; Bahr H; Barakat A; El-Sibai M
Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36102321
[TBL] [Abstract][Full Text] [Related]
12. The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review.
Mohtashami E; Shafaei-Bajestani N; Mollazadeh H; Mousavi SH; Jalili-Nik M; Sahebkar A; Afshari AR
Curr Drug Metab; 2020; 21(8):564-578. PubMed ID: 32664839
[TBL] [Abstract][Full Text] [Related]
13. Topics in chemotherapy, molecular-targeted therapy, and immunotherapy for newly-diagnosed glioblastoma multiforme.
Okonogi N; Shirai K; Oike T; Murata K; Noda SE; Suzuki Y; Nakano T
Anticancer Res; 2015 Mar; 35(3):1229-35. PubMed ID: 25750269
[TBL] [Abstract][Full Text] [Related]
14. The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells.
Bou-Gharios J; Assi S; Bahmad HF; Kharroubi H; Araji T; Chalhoub RM; Ballout F; Harati H; Fares Y; Abou-Kheir W
Pharmacol Rep; 2021 Feb; 73(1):227-239. PubMed ID: 33140310
[TBL] [Abstract][Full Text] [Related]
15. Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside.
Li Y; Sharma A; Maciaczyk J; Schmidt-Wolf IGH
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163235
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.
Kroeger KM; Muhammad AK; Baker GJ; Assi H; Wibowo MK; Xiong W; Yagiz K; Candolfi M; Lowenstein PR; Castro MG
Discov Med; 2010 Oct; 10(53):293-304. PubMed ID: 21034670
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of Therapies for Glioblastoma (GBM) Using Nanoparticle-based Delivery Systems.
Wiwatchaitawee K; Quarterman JC; Geary SM; Salem AK
AAPS PharmSciTech; 2021 Feb; 22(2):71. PubMed ID: 33575970
[TBL] [Abstract][Full Text] [Related]
18. The antitumor action of endocannabinoids in the tumor microenvironment of glioblastoma.
Tang Y; Wang M; Yu J; Lv G; Wang Y; Yu B
Front Pharmacol; 2024; 15():1395156. PubMed ID: 38720772
[TBL] [Abstract][Full Text] [Related]
19. Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme.
Marei HE; Althani A; Afifi N; Hasan A; Caceci T; Pozzoli G; Cenciarelli C
Cancer Med; 2021 Aug; 10(15):5019-5030. PubMed ID: 34145792
[TBL] [Abstract][Full Text] [Related]
20. HER1/EGFR tyrosine kinase inhibitors for the treatment of glioblastoma multiforme.
Raizer JJ
J Neurooncol; 2005 Aug; 74(1):77-86. PubMed ID: 16078112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
